Pfizer/BioNTech vaccine shown to prevent most coronavirus disease 2019 (COVID-19)–related deaths or hospitalizations; extreme weather delays 6 million vaccine doses; post-traumatic stress disorder and anxiety seen in COVID-19 survivors.
According to data collected by Israel’s Health Ministry, the coronavirus disease 2019 (COVID-19) vaccine manufactured by Pfizer and BioNTech is 98.8% effective at preventing death or hospitalization among those who received both doses. Reported by The Hill, Chezy Levy, director-general of Israel’s Health Ministry, said the vaccine also is 99.2% effective against preventing serious cases of COVID-19. Approximately one-third of Israel’s population has been vaccinated.
Last Friday, White House officials confirmed that 6 million doses of COVID-19 vaccines were delayed due to the extreme winter weather conditions across the country. Reported by NPR, the delayed vaccine shipment equals that 3 days’ worth of doses, according to Andy Slavitt, senior adviser on the White House COVID-19 Response Team. Currently, 1.4 million doses are in transit and expected to be delivered in the next several days.
Reported by CIDRAP, the Center for Infectious Disease Research and Policy at the University of Minnesota, 30.2% of 381 patients in Rome who had been hospitalized for COVID-19 received a diagnosis of post-traumatic stress disorder (PTSD) in the 1 to 4 months after their recovery. In findings published in JAMA Psychiatry, the researchers also show elevated rates of depression (17.3%) and generalized anxiety disorder (7%) in the study cohort. Among those with diagnosed PTSD, 16.5% exhibited delirium or agitation when ill and 62.6% reported the persistence of more than 3 coronavirus-related symptoms after recovery from infection.